Lincoff M - Search Results

1

Minimal myocardial damage during coronary intervention is associated with impaired outcome.

Simoons ML, van den Brand M, Lincoff M, Harrington R, van der Wieken R, Vahanian A, Rutsch W, Kootstra J, Boersma E, Califf RM, Topol E. Simoons ML, et al. Among authors: lincoff m. Eur Heart J. 1999 Aug;20(15):1112-9. doi: 10.1053/euhj.1999.1521. Eur Heart J. 1999. PMID: 10413641

2

Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT.

Cho L, Bhatt DL, Wolski K, Lincoff M, Topol EJ, Moliterno DJ. Cho L, et al. Among authors: lincoff m. Am Heart J. 2001 Apr;141(4):599-602. doi: 10.1067/mhj.2001.113573. Am Heart J. 2001. PMID: 11275926

3

Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures.

Ellis SG, Omoigui N, Bittl JA, Lincoff M, Wolfe MW, Howell G, Topol EJ. Ellis SG, et al. Among authors: lincoff m. Circulation. 1996 Feb 1;93(3):431-9. doi: 10.1161/01.cir.93.3.431. Circulation. 1996. PMID: 8565159

4

Utility of CMR Markers of Myocardial Injury in Predicting LV Functional Recovery: Results from PROTECTION AMI CMR Sub-study.

Grover S, Bell G, Lincoff M, Jeorg L, Madsen PL, Huang S, Leow S, Figtree G, Chakrabarty A, Leong DP, Woodman RJ, Selvanayagam JB. Grover S, et al. Among authors: lincoff m. Heart Lung Circ. 2015 Sep;24(9):891-7. doi: 10.1016/j.hlc.2015.03.001. Epub 2015 Mar 24. Heart Lung Circ. 2015. PMID: 25846255 Clinical Trial.

5

Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials.

Giustino G, Mehran R, Bansilal S, Feit F, Lincoff M, Deliargyris EN, Kirtane AJ, Généreux P, Redfors B, Prats J, Bernstein D, Brener SJ, Skerjanec S, Lansky AJ, Francese DP, Dangas GD, Stone GW. Giustino G, et al. Among authors: lincoff m. Am J Cardiol. 2016 Jul 1;118(1):6-16. doi: 10.1016/j.amjcard.2016.04.005. Epub 2016 Apr 20. Am J Cardiol. 2016. PMID: 27181566 Clinical Trial.

6

Clevidipine as a therapeutic and cost-effective alternative to sodium nitroprusside in patients with acute aortic syndromes.

Alviar CL, Gutierrez A, Cho L, Krishnaswamy A, Saleh A, Lincoff MA, Roselli E, Militello M, Menon V. Alviar CL, et al. Among authors: lincoff ma. Eur Heart J Acute Cardiovasc Care. 2020 Oct;9(3_suppl):S5-S12. doi: 10.1177/2048872618777919. Epub 2018 Jun 7. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 29877737

7

Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial.

Yeomans ND, Graham DY, Wang Q, Wolski K, Borer J, Husni EM, Libby P, Lincoff MA, Lüscher T, Wisniewski LM, Bao W, Walker C, Nissen SE. Yeomans ND, et al. Among authors: lincoff ma. Am J Gastroenterol. 2018 Jul;113(7):1053-1054. doi: 10.1038/s41395-018-0051-6. Am J Gastroenterol. 2018. PMID: 29535414 No abstract available.

8

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.

Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F. Campo G, et al. Among authors: lincoff ma. Data Brief. 2017 Jul 18;14:197-205. doi: 10.1016/j.dib.2017.07.033. eCollection 2017 Oct. Data Brief. 2017. PMID: 28795098 Free PMC article.

9

Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial.

Hamon M, Rasmussen LH, Manoukian SV, Cequier A, Lincoff MA, Rupprecht HJ, Gersh BJ, Mann T, Bertrand ME, Mehran R, Stone GW. Hamon M, et al. Among authors: lincoff ma. EuroIntervention. 2009 May;5(1):115-20. doi: 10.4244/eijv5i1a18. EuroIntervention. 2009. PMID: 19577992 Clinical Trial.

10

Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trial.

Koster A, Spiess B, Jurmann M, Dyke CM, Smedira NG, Aronson S, Lincoff MA. Koster A, et al. Among authors: lincoff ma. Anesth Analg. 2006 Sep;103(3):540-4. doi: 10.1213/01.ane.0000226098.95698.0f. Anesth Analg. 2006. PMID: 16931658 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters